Back ground: Op ti mal sur gi cal ap proach to synchro nous colorectal liver metastases is a sub ject of de bate. Aims: This ret ro spec tive study compares the out comes of pa tients un der go ing si multa neous re sec tion or de layed re sec tion. Meth ods: All 238 pa tients un der go ing liver re sec tion between 1995 and 2014 for liver only resectable synchro nous colorectal metastases were in cluded in this study. Out comes were com pared be tween pa tients un der go ing si mul ta neous re sec tion and de layed re section.Re sults: The mor bid ity and mor tal ity rates were sim i lar be tween the two groups p value > 0.05), even in pa tients with rec tal tu mors or un der go ing ma jor hepatectomies. The over all sur vival rates achieved in the SR group were not sig nif i cantly lower than in DR group p value = 0.817), ei ther in N-pos i tive pa tients, or in pa tients pre sent ing mul ti ple liver metastases.Conclu sion: Si mul ta neous re sec tion pro vides sim i lar morbid ity, mor tal ity and sur vival rates as de layed re section, even in N-pos i tive pa tients or those with pri mary rec tal tu mors, mul ti ple metastases or un der go ing major hepatectomies.
C olorectal can cer is the third cause of can cer-re lated death among the adults, most of these pa tients dy ing due to the met a static dis ease 1 . In pa tients with colorectal can cer, the most com mon lo ca tion of the metastases is the liver, al most 70% of these pa tients pre sent ing liver metastases at the time of their death.
Be tween 16 and 25% of pa tients with colorectal can cer pres ent liver metastases at the time of their pri mary tu mor di ag no sis syn chro nous colorectal liver metastases) 2.3 The treat ment of pa tients with colorectal liver metastases is multimodal, in volv ing sur gery, che mo therapy, tar geted ther a pies and, some times, ra dio ther apy. How ever, the high est sur vival rates and even cure) are achieved by pa tients un der go ing rad i cal re sec tion of the pri mary tu mor and com plete re sec tion of liver metastases.
The op ti mal sur gi cal ap proach of syn chro nous colorectal liver metastases CLMs) is still a sub ject of debate 4 . Few de cades ago, it was rec om mended ini tial resec tion of the pri mary tu mor fol lowed by liver re sec tion few months later de layed re sec tion -DR) 5, 6 . In the last two de cades, due to the sur gi cal ad vances mainly in liver re sec tion) and im prove ments in an es the si ol ogy and in tensive care treat ment, in spe cial ized cen ters was per formed si mul ta neous re sec tion of the pri mary tu mor and liver metastases si mul ta neous re sec tion -SR) [7] [8] [9] . The ad vantages of the lat ter ap proach are the avoid ance of two oper a tions un der gen eral an es the sia), the shorter hos pi tal stay and a more rapid re cov ery, re sult ing in a better comfort of the pa tient and a more cost-ef fec tive sur gi cal treatment [10] [11] [12] [13] . More over, the si mul ta neous ap proach avoids the pro gres sion to unresectability of ini tially resectable liver metastases, which is pos si ble dur ing the pe riod between the two op er a tions in the DR ap proach). How ever, the pro mot ers of the de layed ap proach raised con cerns re gard ing the safety and ef fec tive ness of the SR es pecially in pa tients with rec tal tu mors and/or re quir ing major hepatectomies), hy poth e siz ing that the mor bid ity and mor tal ity rates are higher fol low ing si mul ta neous approach, and the "test of time" al lowed by DR could of fer a better se lec tion of pa tients re flected in higher sur vival rates 5, 14 . In this study are com pared the out comes of these two ap proaches, try ing to dis close if one strat egy is su pe rior to the other, even in some groups of pa tients featur ing spe cific char ac ter is tics e.g. pri mary rec tal tu mor, ma jor hepatectomies, etc 
MATERIAL AND METHODS
Pa tients un der go ing liver re sec tion for syn chro nous CLMs were iden ti fied from a da ta base in clud ing all the pa tients with CLMs un der go ing liver re sec tion in "Dan Setlacec" Cen ter of Gen eral Sur gery and Liver Transplan ta tion from Fundeni Clin i cal In sti tute, Bu cha rest, Roma nia.
The in clu sion cri te ria of the pa tients en rolled in the pres ent study were: 1. liver metastases de tected dur ing the work-up for the colorectal can cer or at the time of the op er a tion ad dressed to the pri mary tu mor; 2. CLMs were resectable at the mo ment of their di ag no sis; 3. ab sence of extrahepatic metastases metastases with other lo ca tion than the liver); 4. histologically proven colorectal adenocarcinoma and liver metastases; 5. ab sence of prior liver di rected ther apy e.g. hepatectomy, ab la tive ther apies) for CLMs.
Syn chro nous CLMs were de tected ei ther be fore op er ation by ab dom i nal ultrasonography and com puted to mogra phy CT scan) or mag netic res o nance im ag ing MRI), or intraoperatively by vi sual and palpatory ex am i na tion of the liver and by intraoperative ultrasonography.
The de ci sion to per form si mul ta neous re sec tion or delayed re sec tion was based on the sur geons' opin ion regard ing the safety of the re sec tion tak ing into ac count mainly the clin i cal sta tus of pa tient and the pres ence of pri mary tu mors' com pli ca tions).
CLMs were con sid ered resectable when at least two adja cent liver seg ments could be pre served with ad e quate vas cu lar in flow and out flow and biliary drain age and func tional liver rem nant rep re sented more than 30% of the to tal liver vol ume in pa tients with un der ly ing chronic liver dis ease or re ceiv ing more than 6 cy cles of pre op er ative che mo ther apy the func tional liver rem nant should ex ceed 40% of to tal liver vol ume).
A liver re sec tion was con sid ered as ma jor hepatectomy when ever at least three seg ments were en tirely resected.
Post op er a tive mor bid ity in cluded all wound, liver resec tion, colorectal re sec tion and gen eral) com pli ca tions oc cur ring within 30 days af ter sur gery. Hepatic com pli cations in cluded liver fail ure, hem or rhage at the transsection sur face re quir ing reoperation, bile leak and perihepatic fluid col lec tions. Colorectal com pli ca tions included anastomotic leak, intraabdominal ab scess and peri to ni tis.
Post op er a tive mor tal ity was con sid ered the de cease of a pa tient dur ing post op er a tive hos pi tal iza tion or within 30 days af ter op er a tion.
Chi-square and Fisher's ex act test were used to eval uate the as so ci a tion of in de pend ent vari ables with post oper a tive com pli ca tions and post op er a tive de ceases. Over all sur vival prob a bil i ties fol low ing liver re sec tion were es timated by Kaplan-Meyer method and com pared with the Log rank test. Dif fer ences were con sid ered sta tis ti cally sig nif i cant when p value < 0.05. The sta tis ti cal anal y sis was per formed with SPSS ver sion 13.0 soft ware SPSS, Chi cago, Il li nois, USA).
RESULTS
Be tween Jan u ary 1995 and June 2014, 238 pa tients with liver only ini tially resectable syn chro nous colorectal metastases un der went liver re sec tion. Si mul ta neous resec tion was per formed in 193 pa tients SR group), while 45 pa tients un der went de layed liver re sec tion DR group).
There was a sim i lar dis tri bu tion in the two groups regard ing age, gen der, transmural ex ten sion of the pri mary tu mor T3 and T4) and num ber of liver metastases.
In the SR group there were sta tis ti cal sig nif i cantly more pa tients with pri mary tu mor lo cated within the rec tum than in the DR group Ta ble 1). Lymph node metastases were sig nif i cant more fre quently iden ti fied in the DR group 86% vs 67% I the SR group, p value = 0.0477). The pa tients un der go ing DR un der went sta tis ti cal sig nif icantly more fre quent pre op er a tive che mo ther apy, as well as ma jor hepatectomies Ta ble 1).
Over all, post op er a tive com pli ca tions oc curred in 97 patients tak ing into ac count the com pli ca tions fol low ing both op er a tions in pa tients un der go ing DR). Al though mor bid ity rate was higher in the SR group 41% vs. 37% in the DR group), the dif fer ence was not sta tis ti cally signif i cant p value = 0.7371). In pa tients pre sent ing the same lo ca tion of their pri mary tu mor ei ther co lonic or rec tal), the post op er a tive com pli ca tion rates were not signif i cantly higher fol low ing SR than in pa tients un der going DR Ta ble 2). In pa tients un der go ing ma jor hepatectomies, the mor bid ity rates fol low ing si mul taneous re sec tion 54%) were not sta tis ti cal sig nif i cantly higher than those ob served in pa tients un der go ing DR 50%, p value = 1).
The mor tal ity rates were sim i lar in the SR group and DR group, even in pa tients un der go ing ma jor hepatectomies or pre sent ing pri mary tu mors within the rec tum Ta ble 3). The over all sur vival rates achieved by pa tients un dergo ing SR 85.7%, 50.1% and 30.4% at 1-, 3-and 5-years, re spec tively) were not sta tis ti cal sig nif i cantly dif fer ent p value = 0.817) of those achieved by DR 87.7%, 63% and 29.7% at 1-, 3-and 5-years, re spec tively) Fig ure 1) .
In pa tients with T3/T4 pri mary tu mors, the over all survival rates were not sta tis ti cal sig nif i cantly dif fer ent between SR group 85.9%, 49.4% and 28.6% at 1-, 3-and 5-years, re spec tively) and DR group 85.9%, 62.5% and 25.4% at 1-, 3-and 5-years, re spec tively) -p value = 0.957 Fig ure 2a ).
For N-pos i tive pa tients N1/N2) the over all sur vival rates achieved by SR 84.8%, 46.2% and 25.8% at 1-, 3-and 5-years, re spec tively) were not sta tis ti cal sig nif icantly lower than those achieved by DR 91.3%, 72.1% and 25% at 1-, 3-and 5-years, re spec tively) -p value = 0.519 Fig ure 2b) .
In pa tients with mul ti ple CLMs, al though the over all sur vival rates achieved by DR 86.5%, 62.5% and 31.6% at 1-, 3-and 5-years, re spec tively) were higher than those achieved by SR 78%, 38.9% and 19.8% at 1-, 3-and 5-years, re spec tively), the dif fer ence was not sta tis ti cally sig nif i cant -p value = 0.221 Fig ure 2c) .
The 1-, 3-and 5-years over all sur vival rates of pa tients un der go ing SR with out pre op er a tive che mo ther apy 85.2%, 51.4% and 29.9%, re spec tively) were not sta tis tical sig nif i cantly lower than those achieved by pa tients un der go ing DR af ter neoadjuvant che mo ther apy 93.5%, 67.3% and 33.2% at 1-, 3-and 5-years, re spec tively) -p value = 0.629 Fig ure 2d) .
Also, there were no sta tis ti cal sig nif i cantly dif fer ences be tween the sur vival rates achieved by SR and DR in patients with pri mary tu mor lo cated within the rec tum p value = 0.693), as well as in pa tients un der go ing ma jor hepatectomies p value = 0.979).
DIS CUS SION
De spite the in her ent lim i ta tions of any ret ro spec tive study, this re port re vealed that SR is sim i lar to DR in terms of mor bid ity, mor tal ity and sur vival rates. These re sults are con sis tent with those re ported in sev eral other Br. 2 Si mul ta neous ap proach of colorectal metastases 59 ret ro spec tive stud ies 7, [15] [16] [17] [18] and few re cent meta-anal y sis 18, 19 .
More over, few ret ro spec tive stud ies and meta-anal y sis found a lower mor bid ity rate in pa tients un der go ing SR than in their coun ter part ners that re ceived DR 4, [18] [19] [20] . The au thors re vealed that the most im por tant fac tor con trib uting to this de creased mor bid ity rate fol low ing SR was a bias in duced by the sig nif i cantly lower num ber of metastases in pa tients se lected for this ap proach 20 . In the light of this as sump tion, the sim i lar mor bid ity rates in the two groups of pa tients pre sented in our study may be attrib ut able to the sim i lar per cent age of pa tients with mul tiple CLMs in cluded in the SR and DR group of the present study.
How ever, in the pres ent study, to re duce the bias gen erated by the inhomogeneous char ac ter is tics of the two groups of pa tients re gard ing the lo ca tion of the pri mary tu mor, the fre quency of lymph node metastastases, the per cent age of the pa tients un der go ing ma jor hepatectomies or pre op er a tive che mo ther apy, it was conducted a com par i son be tween out comes of SR and DR tak ing into ac count the sub groups of pa tients fea tur ing sim i lar char ac ter is tics.
Be cause most stud ies pub lished in the last years revealed that SR gen er ates sim i lar mor bid ity and mor tal ity rates as DR in pa tients with pri mary tu mor lo cated within the co lon and re quir ing mi nor hepatectomies [21] [22] [23] [24] [25] , a multidisciplinary in ter na tional con sen sus con fer ence, held in 2012, rec om mended si mul ta neous re sec tion as the treat ment of choice in such pa tients 26 . How ever, in patients whose pri mary tu mor is lo cated within the rec tum and/or re quir ing a ma jor hepatectomy, the Con sen sus rec om men da tions fa vored sep a rate re sec tions ei ther delayed liver re sec tion or liver-first re sec tion), with a level C strength of rec om men da tion, due to the po ten tially higher mor bid ity and mor tal ity rates as so ci ated with SR 26 . In the pres ent study, we com pared the mor bid ity and mor tal ity rates fol low ing SR and DR in pa tients pre senting ei ther pri mary rec tal tu mors or re quir ing ma jor hepatectomies. In these groups of pa tients, the mor bid ity rates fol low ing SR were not sta tis ti cal sig nif i cantly higher than the mor bid ity rates of both op er a tions in the 60 I. Popoecu ACI Vol.LXI More over, the mor tal ity rates fol low ing SR and DR in pa tients with pri mary rec tal tumors or re quir ing ma jor hepatectomies were equal p value = 1). Al though other au thors re vealed sta tis ti cal sig nif i cantly higher mor bid ity and mor tal ity rates af ter SR in pa tients with rec tal tu mors and/or un der go ing major liver re sec tions 14, 22, 23 , our find ings are con cor dant with sim i lar re ports pub lished in the last de cade 16, 27 . How ever, our in sti tu tions' pol icy is to avoid the per formance of a si mul ta neous re sec tion when liver metastases are noted on ex plo ra tion for emer gency colorectal re section per fo ra tion, ob struc tion or bleed ing). In se lected patients re quir ing dif fi cult rec tal re sec tions or de mand ing hepatectomies, in the last year, we pre ferred the liver first ap proach, which avoids the po ten tially higher risks of a si mul ta neous re sec tion, of fer ing the chance of a po tentially cu ra tive liver re sec tion to more pa tients with synchro nous CLMs than the de layed ap proach. In the two pa tients un der go ing "liver-first ap proach" there was noted no one com pli ca tion fol low ing two ma jor hepatectomies and two colorectal re sec tions.
Al though pri mary tu mor re sec tion can be safely as so ciated with liver re sec tion in most pa tients with syn chronous CLMs, con cerns re gard ing the long-term out comes of pa tients un der go ing SR were raised by the sup port ers of the DR ap proach, based on sev eral the o ret i cal as sumptions: 1. pre op er a tive che mo ther apy de liv ered dur ing the in ter val be tween the first and the sec ond op er a tion) could elim i nate dor mant tu mor cells, thus re duc ing the re currence rates af ter de layed re sec tion; 2. dur ing the in ter val be tween the two op er a tions could be as sessed the ag gressive ness of the tu mor, avoid ing a use less liver re sec tion in pa tients whose metastases prog ress un der che mo therapy; 3. the ob ser va tion in ter val al lows a better se lec tion of pa tients for hepatectomy, im prov ing sur vival rates after de layed re sec tion; 4. the re sponse and/or tolerability to pre op er a tive che mo ther apy may guide post op er a tive chemotherapic reg i men [28] [29] [30] . Hence, in the pres ent study, the over all sur vival rates of pa tients un der go ing SR were not sta tis ti cal sig nif i cantly lower than those achieved by DR p value = 0.817). More over, to better eval u ate the abil ity of pre op er a tive Br. 2 Si mul ta neous ap proach of colorectal metastases 61 che mo ther apy to im prove sur vival fol low ing liver re section, we com pared the sur vival rates of pa tients un der going SR with out neoadjuvant che mo ther apy with those achieved by pa tients un der go ing DR af ter pre op er a tive che mo ther apy. Al though the sur vival rates were higher in pa tients un der go ing DR af ter che mo ther apy than in simul ta neous resected pa tients with out pre op er a tive chemo ther apy, the dif fer ence was not sta tis ti cally sig nif i cant p value = 0.629). These re sults, which are con cor dant with those al ready re ported by other au thors deal ing with this sub ject , could be ex plained by the fact that short-course che mo ther apy is not able to dif fer en ti ate the re spond ers by non-re spond ers. This fact could be expected, tak ing into ac count that in most re cent stud ies, the pa tients pre sent ing unresectable CLMs achieved a me dian pro gres sion-free sur vival af ter the first-line chemo ther apy lon ger than 6 months 9, 32, 33 . Thus, a pro longed in ter val be tween the first and sec ond re sec tion should be nec es sary to better se lect the pa tients, but such an extended in ter val could ex pose the pa tients at two dan gerous sce nar ios: 1. The higher num ber of pre op er a tive chemo ther apy cy cles in creases the risk of che mo ther apy-induced liver in jury, in creas ing the mor bid ity and even tually) mor tal ity rates af ter hepatectomy [34] [35] [36] ; 2. The ini tially resectable CLMs could prog ress to unresectability dur ing this ob ser va tion in ter val. Be cause both of these sit u a tions jeop ar dize the chance for a long-term sur vival of pa tients with ini tially resectable syn chro nous CLMs, such a prolonged ob ser va tion in ter val is not ac cept able.
How ever, dif fer ent au thors iden ti fied few fac tors cor related with a poor prog no sis in pa tients with syn chro nous CLMs, hy poth e siz ing that in such sit u a tions the DR could im prove the sur vival rates due to the ben e fi cial effects of prehepatectomy che mo ther apy and better se lection of pa tients). Among these fac tors were mul ti ple CLMs, lo cally ad vanced pri mary tu mors T3/T4), the pres ence of lymph nodes metastases N-pos i tive pa tients) 13, 37, 38 . To eval u ate whether DR rep re sents a more ef fi cient strat egy than SR in such pa tients, there were com pared over all sur vival rates achieved by these two ap proaches in each cat e gory of pa tients.
Al though other re ports 37, 39, 40 sug gested that in pa tients with mul ti ple syn chro nous CLMs the over all sur vival rates achieved by DR are sig nif i cant sta tis ti cally higher than those achieved by SR, in the pres ent study, the survival rates achieved by SR and DR were sim i lar, both in pa tients pre sent ing at least two CLMs p value = 0.221) and in pa tients with more than three metastases p value = 0.782). More over, few years ago we found that the lymph node metastases are an im por tant pre dic tor of poor survival in pa tients with syn chro nous CLMs, hy poth e siz ing that de layed re sec tion af ter pre op er a tive che mo ther apy) may im prove the long-term out comes 13 . In the pres ent study we did not found any sta tis ti cal sig nif i cantly dif ference be tween sur vival rates achieved by SR and DR, neither in N-pos i tive pa tients, nor in N2 pa tients p value > 0.05). Sim i lar re sults were re ported by other ret ro spec tive stud ies which dem on strated that the use of prehepatectomy che mo ther apy does not change the dis mal out come of pa tients with poor prog nos tic in di ca tors of dis ease and there fore does not al ter long-term sur vival 37, 41 . Al though other au thors con sider that SR is pref er a ble due to its short-term re sults re gard ing safety and com fort of the pa tient) but has a neg a tive im pact on long-term out come, the pres ent re port sug gest that DR does not offer any ben e fit over SR in terms of safety and ef fi cacy for pa tients with syn chro nous CLMs. More over, the par tisans of the DR do not take into ac count, when com pare the sur vival rates af ter SR and DR, the pa tients sched uled for o DR) whose metastases prog ress dur ing "ob ser va tion in ter val" and did not un dergo liver re sec tion drop-off patients). Thus, an in ten tion to treat anal y sis, com par ing SR and DR, could no lon ger re veal the sur vival ben e fit of DR, but a study aim ing di rectly this ques tion is not available.
To over come the draw backs of both SR and DR approaches, in the last years, a new onco-sur gi cal ap proach emerged to treat the pa tients with syn chro nous CLMs, espe cially those with rec tal tu mors or bor der-line resectable CLMs. This ther a peu tic strat egy, called "liver first re section", con sists in pre op er a tive che mo ther apy, fol lowed by hepatectomy and sub se quent colorectal re sec tion. More over, the pa tients with rec tal can cer may un dergo ra dio ther apy dur ing the in ter val be tween the two op er ations. The "liver first re sec tion" seems to be more con venient in such pa tients be cause it com bines the ad van tages of the two pre vi ous men tioned ap proaches. Thus, in patients with pri mary rec tal tu mors or re quir ing ma jor hepatectomies, for whom dif fer ent re ports raised concerns re gard ing the safety of a si mul ta neous ap proach, this new strat egy of fers a staged re sec tion of their ma lignant bur den, de creas ing the cu mu la tive risk of a si mul taneous dif fi cult colorectal and liver re sec tion. By an oncologic point of view, sim i lar to the de layed liver resec tion, these ap proach of fers to the pa tients pre sent ing poor prog nos tic fac tors the ad van tages of the prehepatectomy che mo ther apy. Un like DR ap proach, in which high lev els of growth fac tors are re leased fol lowing the pri mary tu mor re sec tion stim u lat ing CLMs growth and mak ing pos si ble their pro gres sion to unresectability, the "liver first" ap proach al lows ini tial clear ance of the metastases 42, 43 . Be cause most pa tients with syn chro nous CLMs de cease due to their metastases pro gres sion, this ap proach avoids pro gres sion to unresectability of their ini tially resectable CLMs, increas ing the chance of a long term sur vival. More over, in pa tients with ini tially unresectable or bor derline-resectable metastases, pre op er a tive che mo ther apy as so ci ated with tar geted ther a pies) could down-size CLMs ren der ing resectable. In such in stances, "liver first ap proach" of fers the chance of a po ten tially cu ra tive liver re sec tion, avoid ing metastases re-growth which would com pro mise the chance of long-term sur vival in such patients.
In con clu sion, si mul ta neous re sec tion of the pri mary tumor and colorectal liver metastases pro vides sim i lar morbid ity, mor tal ity and sur vival rates as de layed re sec tion. Even in pa tients with pri mary rec tal tu mors or un der go -ing ma jor hepatectomies, the mor bid ity and mor tal ity rates af ter SR were not higher than those ob served follow ing DR. In pa tients with syn chro nous colorectal liver metastases pre sent ing poor prog nos tic fac tors N-pos i tive, mul ti ple metastases) the sur vival rates were not im proved by DR. "Liver first re sec tion" is a prom is ing onco-sur gical strat egy, able to over come the dis ad van tages of SR and DR, par tic u larly in pa tients with rec tal tu mors, requir ing ma jor hepatectomies, or pre sent ing poor prog nostic fac tors.
SUMMARY SIMULTANI PRISTUP PRIMARNOM KOLOREKTALNOM KARCINOMU I METASTAZAMA U JETRI
Optimalni hirurški pristup sinhronim kolorektalnim metastazama je predmet de bate. Cilj: Ova retrospektivna studija poredi ishode leèenja pacijenata od kojih su neki bili podvrgnuti simultanoj, a neki odloženoj resekciji jetre. Metode: U ovu studiju smo ukljuèili svih 238 pacijenata kojima je uèinjena resekcija jetre u periodu od 1995 do 2014 godine zbog resektabilnih kolorektalnih metastaza koje su se javile samo u jetri. Rezultati su poredjeni izmedju grupa sa simultanom i odloženom resekcijom jetre. Rezultati: Stopa morbiditeta i mortaliteta je slièna izmeðu ove dve grupe p>0.05), èak i kod pacijenata sa tumorom rektuma ili kod kojih je raðena opsežnija hepatektomija. Ukupna stopa preživljavanja u grupi sa simultanom resekcijom nije bila znaèajno niža od grupe sa odloženom p=0.817), bilo da se radi o pozitivnom N statusu ili multiplim metastazama u jetri. Zakljuèak: Simultane resekcije uzrokuju sliènu stopu morbiditeta, mortaliteta i preživljavanja kao i odložena resekcija, èak i kod N pozitivnih pacijenata ili kod onih sa primarnim karcinomom rektuma, multiplim metastazama ili onima podvrgnutim opsežnim resekcijama jetre.
Kljuène reèi: metastaze kolorektalnog karcinoma, simultani pristup
